Detalhe da pesquisa
1.
Safety, efficacy and acceptability of outpatient mifepristone-misoprostol medical abortion through 70 days since last menstrual period in public sector facilities in Mexico City.
Reprod Health Matters
; 22(44 Suppl 1): 75-82, 2015 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-25702071
2.
Preventing first births among adolescents in Mexico City's public abortion programme.
BMJ Sex Reprod Health
; 47(3): e9, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33452057
3.
Contraceptive Receipt Among First-Trimester Abortion Clients and Postpartum Women in Urban Mexico.
Int Perspect Sex Reprod Health
; 46(Suppl 1): 35-43, 2020 12 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-33326398
4.
Twelve years after abortion decriminalization in Mexico City: Can we still remain an island of liberties?
Best Pract Res Clin Obstet Gynaecol
; 62: 63-78, 2020 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-31501010
5.
A repeat dose of misoprostol 800 mcg following mifepristone for outpatient medical abortion at 64-70 and 71-77 days of gestation: A retrospective chart review.
Contraception
; 102(2): 104-108, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32474060
6.
A non-inferiority study of outpatient mifepristone-misoprostol medical abortion at 64-70 days and 71-77 days of gestation.
Contraception
; 101(5): 302-308, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32014520
7.
Sociodemographic factors associated with obstacles to abortion care: findings from a survey of abortion patients in Mexico City.
Womens Health Issues
; 21(3 Suppl): S16-20, 2011.
Artigo
em Inglês
| MEDLINE | ID: mdl-21530832
8.
Proteína C reactiva como detector temprano de carioamnioitis en ruptura prematura de membranas / C-Reactive protein as an early as an early detector of choriommioitis in premature rupture of membranes
Ginecol. obstet. Méx
; 57: 203-8, oct. 1989. ilus, tab
Artigo
em Espanhol
| LILACS | ID: lil-93698